Brief: Reig Jofre Invests 5.8 Mln Euros In Leanbio In Production Of Biotechnological Medicines
08/04/2024 16:18
April 8 (Reuters) - Laboratorio Reig Jofre SA RJFE.MC :
* RELEASES PRESS NOTE REGARDING ITS COMMITMENT TO VERTICAL
INTEGRATION IN THE PRODUCTION OF BIOTECHNOLOGICAL MEDICINES
* COMMITMENT TO VERTICAL INTEGRATION IN THE PRODUCTION OF
BIOTECHNOLOGICAL MEDICINES WITH AN INVESTMENT OF 5.8 MILLION
EUROS IN LEANBIO
* INVESTMENT AIMS TO ACHIEVE VERTICAL INTEGRATION IN
DEVELOPMENT,
CHARACTERIZATION, AND PRODUCTION OF BIOTECHNOLOGICAL ACTIVE
INGREDIENTS
* TRANSITIONS FROM PHARMACEUTICAL FILL & FINISH PROCESS TO
VERTICAL INTEGRATION IN PRODUCTION OF INNOVATIVE
BIOTECHNOLOGICAL AND BIOSIMILAR PRODUCTS
* INVESTMENT TO ENABLE REIG JOFRE AND LEANBIO TO OFFER
INTEGRATED
SERVICES ACROSS ENTIRE DEVELOPMENT AND INDUSTRIAL SCALING CHAIN
FOR COMMERCIALIZATION OF RECOMBINANT PROTEINS, ANTIBODIES, AND
ADVANCED THERAPIES
* OPERATION, FUNDED THROUGH COMBINATION OF CAPITAL AND DEBT,
HAS
BEEN SPEARHEADED BY CO IN CONJUNCTION WITH OTHER LEANBIO
PARTNERS
* THIS ADVANCE IS FACILITATED THROUGH COLLABORATION WITH
LEANBIO,
IN WHICH REIG JOFRE HAS HELD A 10% STAKE TO DATE
* AS A RESULT CO WILL INCREASE ITS STAKE IN LEANBIO TO REACH
24%,
COMMITTING TO FURTHER INCREASE ITS PRESENCE AS EXPANSION PLAN
PROGRESSES
* PLANT LOCATED IN SANT QUIRZE DEL VALLÈS, IN THE PROVINCE
OF
BARCELONA (SPAIN)
* PLANT PROJECTED TO BE OPERATIONAL BY MID-2025
* TEAM IS EXPECTED TO EXCEED 100 PEOPLE AS PLANT REACHES ITS
PEAK
PERFORMANCE BY 2030
Source text for Eikon: ID:nCNM40kjkF
Further company coverage: RJFE.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))